01 / RESEARCH SUMMARY
Dihexa Research Summary
Peptide analog of angiotensin IV with potent neurotrophic activity. Promotes synaptogenesis and is investigated for memory and cognitive impairment.
Read the full guide →02 / DOSING & RECONSTITUTION
Dosing & Reconstitution Guide
Supplied community-reported range (unverified) is shown below.
The calculator is a pure mass-and-volume math tool. Generic inputs are not compound-specific vial sizes or preparation instructions; IU, weight-based, percentage and ready-made solution ranges are not converted into mg doses.
| Protocol | Dose range |
|---|---|
| Community-reported range (unverified) | 1–8 mg/day PO/SC |
Community-reported range (unverified); not a clinically verified schedule.
03 / RECONSTITUTION CALCULATOR
Mix & measure Dihexa · 5 mg
Generic mass-and-volume inputs only — enter your own values. No compound-specific dose or preparation is recommended.
- CONCENTRATION
- 2.50 mg/mL
- DRAW VOLUME
- — mL
- ON THE SYRINGE
- — units
- DOSES / VIAL
- —
Reconstitution math only. U-100 syringe: 100 units = 1 mL.
Reconstitution GuideFull calculator →04 / STORAGE
Storage Instructions
No compound-specific storage or preparation instructions were supplied. Follow the exact formulation's documented requirements.
05 / RESEARCH FINDINGS
What Research Shows
Preclinical / limited human evidence
- Improved memory formation
- Synaptic connectivity
- Neurogenesis support
- Cognitive resilience
Research context
The supplied research does not establish all listed outcomes or a validated human dosing protocol.
06 / MOLECULAR BIOLOGY
Mechanism of Action
Supplied research description
Proposed research targets
Peptide analog of angiotensin IV with potent neurotrophic activity. Promotes synaptogenesis and is investigated for memory and cognitive impairment.
Adamantane & the blood–brain barrier
Chemically attaching an adamantane group to a peptide can increase its lipid (fat) solubility. Researchers hypothesize that this modification may help certain compounds cross the tightly regulated blood–brain barrier. The effect depends on the specific modified molecule; greater lipid solubility alone does not establish brain delivery or clinical benefit. This does not apply automatically to the unmodified peptide and is not a reconstitution additive.
07 / STUDIES
Studies & references
08 / SAFETY
Safety considerations
- Verify the active identity, lot number, and matching certificate of analysis. Testing does not by itself establish sterility or suitability for human use.
- Follow documented product-specific storage and preparation requirements; stability and diluent compatibility depend on the formulation.
- Research powders are not interchangeable with prescription formulations. Do not infer an injection or nasal protocol from a concentration calculation.
- For medical care, pregnancy, existing conditions, or medication interactions, consult a qualified healthcare professional.
09 / RECOMMENDED SOURCE
Recommended Source
Not currently carried by Orbitrex.
Compare research suppliers →